Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

RPR forms worldwide research collaboration to study Taxotere-based combinations

March 6, 1997

MGH to evaluate Cheung breast cancer treatment system in animals

March 6, 1997

Selective, nonpeptide inhibitor of Ras farnesylation discovered by Schering-Plough

March 6, 1997

MAb for metastasis or ischemia reported by BU

March 6, 1997

TK inhibitors from Novartis

March 6, 1997

Oral mucositis treatment proceeds to phase II

March 5, 1997

Update on Sparta's asulacrine

March 5, 1997

Caelyx available in additional countries

March 5, 1997

Orally active inhibitor of Ras farnesylation reported by Schering-Plough

March 5, 1997

Steroidal antitumor agents described by Taisho

March 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...